Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Losses Mount For Medicare Drug Negotiation Challengers No Photo Available

Yeji Jesse Lee

Big Pharma's losses in challenges to Medicare drug price negotiations are piling up. But don't think the industry is ready to wave the white flag.

High Court Interest In Health Sharing Ministry Case No Photo Available

Hannah Albarazi

The U.S. Supreme Court is showing interest in a challenge to state regulatory authority over health care sharing ministries. The nonpr... (more story)

Chatbots And Mental Health: Cases And New Laws To Know No Photo Available

Dan McKay

A Texas investigation into the marketing of chatbots as a mental health tool adds to the growing scrutiny on the use of the bots to mi... (more story)